Company / R&D per Share
SOLENO THERAPEUTICS INC R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.78
FY2025
5-year range
$0.78 / $4.03
FY2021-FY2025
Trend
-60.3%
vs FY2024
Sector context
#155 of 207
Health Care
What the data says
SOLENO THERAPEUTICS INC's r&d per share of $0.78 is lower than 75% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 10 years, ranging from $0.16 in FY2016 to $4.03 in FY2021.
Based on SEC 10-K filings.
0.78 in FY2025 with a 5-year CAGR of +15.9%.
Declined from $1.53 to $0.78 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -24.7%
- 5-Year CAGR
- +15.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 207This company $0.78 Sector average $12.26
▼
-93.7% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 60.3% year-over-year.
- Ranks #155 out of 207 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2021.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.78 | -60.3% |
| FY2024 | $1.96 | +28.0% |
| FY2023 | $1.53 | -16.0% |
| FY2022 | $1.82 | -54.9% |
| FY2021 | $4.03 | +989.3% |
| FY2020 | $0.37 | -22.3% |
| FY2019 | $0.48 | +39.2% |
| FY2018 | $0.34 | +0.1% |
| FY2017 | $0.34 | +113.2% |
| FY2016 | $0.16 | -76.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026